MedTrace Logo

Immunological Markers Screening for Colorectal Cancer

NCT02222753 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2014-08-21

No results posted yet for this study

Summary

Colorectal cancer incidence is increasing at an alarming rate in China. Recent reports concluded aberrant immunological function was associated with colorectal cancer outcome, however, the influence of immunocyte subgroup and immunologic factors on cancer outcome in colorectal cancer survivors is largely unknown.The investigators will explore the impact of immunocyte subgroup and immunologic factors on colorectal cancer disease-specific, disease-free and overall survival. The investigators will recruit approximately 5,000 patients as a prospective study cohort. During follow up, the investigators will explore the association of these factors with outcome of patients. The investigators believe that this project will improve the understanding of the impact of immunocyte subgroup and immunologic factors on colorectal cancer outcome.

Conditions

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Air Force Military Medical University, China

    collaborator OTHER

  • Second Military Medical University

    collaborator OTHER

  • China-Japan Friendship Hospital

    collaborator OTHER

  • Chinese Academy of Medical Sciences

    collaborator OTHER

  • Peking University Cancer Hospital & Institute

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • State Key Laboratory of Cancer Biology

    lead NETWORK

Principal Investigators

  • Long Cui, M.D. · Shanghai Jiao Tong University School of Medicine

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02222753 on ClinicalTrials.gov